ANNEXON INC. - COMMON STOCK

Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results

13 ноя 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Biosciences to Participate in 2023 Jefferies London Healthcare Conference

09 ноя 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Receives PRIME Designation from the EMA for ANX007 for the Treatment of Geographic Atrophy

24 окт 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

18 окт 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Announces Clinical and Regulatory Progress for ANX005 Pivotal Program in Guillain-Barré Syndrome (GBS)

10 окт 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Biosciences to Participate in the 2023 Cantor Global Healthcare Conference

19 сен 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

18 сен 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Highlights Recent Pipeline and Business Progress and Reports Second Quarter 2023 Financial Results

07 авг 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

02 авг 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy

30 июл 2023 11:00:00 Источник Nasdaq GlobeNewswire

Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer

27 июл 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Topline Data from ARCHER Phase 2 Trial of ANX007 in Geographic Atrophy Demonstrated Statistically Significant, Dose-Dependent Preservation of Visual Function

24 май 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

16 май 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Reports First Quarter 2023 Financial Results and Highlights Recent Pipeline Progress

08 май 2023 15:01:00 Источник Nasdaq GlobeNewswire

Annexon Biosciences to Participate in the 22nd Annual Needham Virtual Healthcare Conference

11 апр 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones

06 мар 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Biosciences to Participate in the 43rd Annual Cowen Healthcare Conference

27 фев 2023 05:30:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

16 фев 2023 15:05:00 Источник Nasdaq GlobeNewswire

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

17 янв 2023 15:30:00 Источник Nasdaq GlobeNewswire

Annexon Highlights Strategic Focus to Advance Four Flagship Complement Programs through Late-Stage Development and Progress Across Three Therapeutic Franchises

08 янв 2023 08:00:00 Источник Nasdaq GlobeNewswire